Clinical pharmacology of antilipemic agents
Cuena Boy, R.; Azanza Perea, J.R.; Honorato Pérez, J.
Revista de Medicina de la Universidad de Navarra 27(1): 25-28
1983
ISSN/ISBN: 0556-6177 PMID: 6669829 Document Number: 215779
Document emailed within 1 workday
Related Documents
Takekoshi, N.; Murakami, E. 1980: Present status of antilipemic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 38(9): 3138-3148Brun, J.; Ohlsson-Onerud, A.; Sörensen, N. 2009: Pfizer: TLV decision about antilipemic agents is founded on wrong basis Lakartidningen 106(17): 1193-1194; Discussion 1194
Hellström, K. 1988: New guidelines for the management of hyperlipidemia: change of diet is more effective than antilipemic agents Lakartidningen 85(45): 3807-3808
Rahn, K.H. 1975: Clinical pharmacology of anti-arrhythmia agents Medizinische Klinik 70(23): 994
Roden, D.M. 1985: Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents Postgraduate Medicine 78(4): 28-37
Rahn, K.H. 1983: Clinical pharmacology of the newer antihypertensive agents Der Internist 24(3): 128-134
Zeng, G.Y. 1983: Clinical pharmacology of anti-arrhythmia agents Zhonghua Xin Xue Guan Bing Za Zhi 11(1): 15-19
Azanza Perea, J.R.; Honorato Pérez, J.M.; Cuena Boy, R. 1984: Clinical pharmacology of anti-arrhythmia agents Revista de Medicina de la Universidad de Navarra 28(1): 37-43
Colace, F. 1970: Pharmacology and clinical use of adrenergic beta-blocking agents Il Policlinico. Sezione Pratica 77(20): 645-656
Votchal, B.E.; Zamotaev, I.P.; Maksimova, L.N. 1975: Clinical pharmacology of bronchodilator agents of the sympathomimetic series Klinicheskaia Meditsina 52(5): 43-46
Louis, R.; Radermecker, M. 1991: Anti-asthmatic agents. from pharmacology to clinical aspects Revue Medicale de Liege 46(2): 58-81
Witkowska, M. 1981: Clinical pharmacology of anti-arrhythmia agents. I. Quinidine, procainamide and disopyramide Kardiologia Polska 24(7): 505-517
Chekman, I.S. 1998: The clinical pharmacology of hypotensive agents. Angiotensin-converting enzyme inhibitors Likars'ka Sprava 4: 22-26
Gjerden, P.; Slørdal, L. 1998: Clinical pharmacology of anticholinergic antiparkinson agents. a review with emphasis on acute toxicity Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(1): 53-55
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Vyas, B. 2001: European Association of Clinical Pharmacology and Therapeutics--Fifth Congress. Clinical pharmacology: from molecule to society--bridging the gap via Man IDrugs: the investigational drugs journal 4(10): 1133-1137
Poulsen, H.Enghusen.; Schmitz, O.E.; Brøsen, K. 2002: Clinical pharmacology 2001--important events. The Danish Society of Clinical Pharmacology Ugeskrift for laeger 164(12): 1652
Duchêne-Marullaz, P. 1977: Pharmacology, clinical pharmacology and therapeutic effects of Royat's thermal gas Semaine des Hopitaux. Therapeutique 53(7-8): 361-362
Kwapiszewski, W.; Borkowski, L. 1987: Amino acid derivatives of 2-(p-chlorophenoxy)-2-methylpropionic acid as compounds with potential antilipemic agents. II. Preparation of methyl esters of N-[2-(p-chlorophenoxy)-2-methylpropionyl] amino acids Acta Poloniae Pharmaceutica 44(2): 121-131
Mezey, K.C. 1974: Pharmacology of antihypertensive agents Schweizerische Rundschau für Medizin Praxis 63(20): 612-617